{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:33Z","timestamp":1787261013135,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ctro.2026.101230","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:46Z","timestamp":1784302126000},"page":"101230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Daily adaptive radiotherapy in postoperative hypofractionated salvage radiothERapy for prostate cancer patients (DART-PHASER): Early clinical and dosimetric results"],"prefix":"10.1016","volume":"60","author":[{"given":"Luca","family":"Nicosia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo Filippo","family":"Borgese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Orsatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Gaetano","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De-Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Fiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gurrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pastorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ricchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Romei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluisa","family":"Sicignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Guardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Salgado Gonz\u00e0les","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101230_bb0005","unstructured":"European Commission. Estimates of cancer incidence and mortality in 2020, for all countries. Eur Com (2020). Online access on 8 November 2022. https:\/\/ecis.jrc.ec.europa.eu\/explorer.php?$0-1$1-All$2-All$4-1,2$3-0$6-0,85$5\u20132004,2010$7\u20132$CRatesByRegistry$X0_10-ASR_EU_NEW."},{"issue":"3","key":"10.1016\/j.ctro.2026.101230_bb0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":"Adjuvant radiotherapy for pathologic T3N0M0 prostate Cancer significantly reduces risk of metastases and improves survival: long-term Followup of a randomized clinical trial","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"issue":"9858","key":"10.1016\/j.ctro.2026.101230_bb0015","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2026.101230_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","article-title":"Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/AUO AP 09\/95 trial","volume":"66","author":"Wiegel","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101230_bb0025","first-page":"716","article-title":"Current controversies in the management of biochemical failure in prostate cancer","volume":"10","author":"Bruce","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101230_bb0030","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10260","key":"10.1016\/j.ctro.2026.101230_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ctro.2026.101230_bb0040","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S1470-2045(20)30454-X","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial","volume":"21","author":"Sargos","year":"2020","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101230_bb0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11547-018-0890-7","article-title":"Could 68-ga PSMA PET\/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series","volume":"123","author":"De Bari","year":"2018","journal-title":"Radiol Med"},{"issue":"Suppl. 5","key":"10.1016\/j.ctro.2026.101230_bb0050","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.21037\/tau.2019.12.34","article-title":"New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: is the era of melting glaciers upcoming?","volume":"8","author":"Mazzola","year":"2019","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ctro.2026.101230_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.euros.2020.10.001","article-title":"Hypofractionated postoperative radiotherapy for prostate Cancer: is the field ready yet?","volume":"22","author":"Mahase","year":"2020","journal-title":"European Urology Open Science"},{"key":"10.1016\/j.ctro.2026.101230_bb0060","series-title":"European Association of Urology (EAU) prostate cancer guidelines","year":"2026"},{"key":"10.1016\/j.ctro.2026.101230_bb0065","series-title":"National Comprehensive Cancer Network (NCCN) prostate cancer guidelines","year":"2026"},{"issue":"4","key":"10.1016\/j.ctro.2026.101230_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.eururo.2009.05.041","article-title":"Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy forprostate cancer: clinical results in 104 patients","volume":"56","author":"Ost","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2026.101230_bb0075","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1200\/JCO.2015.63.3529","article-title":"Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09\/10","volume":"33","author":"Ghadjar","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101230_bb0080","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2008.12.059","article-title":"Need for high radiation dose (>70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients","volume":"75","author":"Cozzarini","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101230_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/0284186X.2013.837584","article-title":"Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: toxicity analysis","volume":"53","author":"Zilli","year":"2014","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101230_bb0090","first-page":"48","article-title":"Role of dose intensification for salvage radiation therapy after radical prostatectomy","volume":"1","author":"Beck","year":"2016","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101230_bb0095","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/0284186X.2012.719635","article-title":"Prostate alpha\/beta revisited -- an analysis of clinical results from 14 168 patients","volume":"51","author":"Dasu","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ctro.2026.101230_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ctrv.2017.11.004","article-title":"Hypofractionated radiotherapy for prostate cancer in the postoperative setting: what is the evidence so far?","volume":"62","author":"Picardi","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.ctro.2026.101230_bb0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-019-1325-x","article-title":"Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial","volume":"14","author":"Koerber","year":"2019","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101230_bb0115","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijrobp.2023.04.032","article-title":"Salvage radiation therapy after radical prostatectomy: analysis of toxicity by dose-fractionation in the RADICALS-RT trial","volume":"117","author":"Petersen","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"10.1016\/j.ctro.2026.101230_bb0120","first-page":"03160","article-title":"Quality-of-life outcomes and toxicity profile among patients with localized prostate Cancer after radical prostatectomy treated with stereotactic body radiation: the SCIMITAR Multicenter phase 2 trial","volume":"S0360-3016","author":"Ma","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"44","key":"10.1016\/j.ctro.2026.101230_bb0125","article-title":"Toxicity profile and Patient-reported outcomes following salvage stereotactic ablative radiation therapy to the prostate bed: the POPART multicentric prospective study","volume":"25","author":"Ferrario","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101230_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC radiation oncology group","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101230_bb0140","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.3390\/cancers13112802","article-title":"Interfractional geometric variations and Dosimetric benefits of stereotactic MRI guided online adaptive radiotherapy (SMART) of prostate bed after radical prostatectomy: post-hoc analysis of a phase II trial","volume":"13","author":"Cao","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101230_bb0145","article-title":"Intra-fractional geometric and dose\/volume metric variations of magnetic resonance imaging-guided stereotactic radiotherapy of prostate bed after radical prostatectomy","volume":"30","author":"Gao","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101230_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109631","article-title":"The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: post-hoc analysis of a phase II clinical trial","volume":"183","author":"Nikitas","year":"2023","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101230_bb0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11547-022-01479-4","article-title":"Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis","volume":"127","author":"Nicosia","year":"2022","journal-title":"Radiol Med"},{"key":"10.1016\/j.ctro.2026.101230_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2020.04.007","article-title":"Prostate bed and organ-at-risk deformation: prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy","volume":"148","author":"Yoon","year":"2020","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101230_bb0165","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prro.2018.08.002","article-title":"Hypofractionated radiation therapy for localized prostate Cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline","volume":"8","author":"Morgan","year":"2018","journal-title":"Pract Radiat Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:24:51Z","timestamp":1787257491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2405630826001254"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101230","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily adaptive radiotherapy in postoperative hypofractionated salvage radiothERapy for prostate cancer patients (DART-PHASER): Early clinical and dosimetric results","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101230"}}